Hyaluronan: Fundamental principles and applications in cancer

Journal of Internal Medicine

Volumn 242, Issue 1, 1997, Pages 41-48

  Delpech, B ^a   Girard, N ^a   Bertrand, P ^a   Courel, M N ^a   Chauzy, C ^a   Delpech, A ^a  

^a CENTRE HENRI BECQUEREL   (France)

Author keywords

Adhesion; Cancer; Hyaluronan; Hyaluronan binding sites; Hyaluronan binding proteins; Invasion

Indexed keywords

FIBRONECTIN; HERMES ANTIGEN; HYALURONECTIN; HYALURONIC ACID; HYALURONIDASE; LAMININ; VERSICAN;

BINDING SITE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURFACE; CONFERENCE PAPER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNOLOGY;

EID: 0030754280     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00172.x     Document Type: Conference Paper

References (60)

1. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397-404.
2. Prehm P. Synthesis of hyaluronate in differentiated teratocarcinoma cells. Biochem J 1983; 211: 191-8.
3. Delpech B, Bertrand P, Hermelin B, Delpech A, Girard N, Halkin E, Chauzy C, Hyaluronectin. In: Labat-Robert J, Timpl R, Robert L. eds. Frontiers of Matrix Biology, Vol. XI. Karger: Basel, 1986: pp. 78-89.
4. Delpech B, Halavent C. Characterization and purification from human brain of a hyaluronic acid-binding glycoprotein, hyaluronectin. J Neurochem 1981; 36: 855-9.
5. Namboodiri MSA, Zhang P, Bhat NR. Hyaluronectin binds to laminin and blocks laminin-dependent process formation by astrocytes. Neuroreport 1995; 6: 2037-40.
6. Bertrand P, Delpech B. Interaction of hyaluronectin with hyaluronic acid oligosaccharides. J Neurochem 1985; 45: 434-9.
7. Marret S, Delpech B, Delpech A, Asou H, Girard N, Courel MN, Chauzy C, Maingonnat C, Fessard C. Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures. J Neurochem 1994; 62: 1285-95.
8. Delpech B, Girard N, Vannier JP, Tilly H, Piguet H. Production d'une glycoproteine affine pour l'hyaluronane par les monocytes du sang humain. Son utilisation comme marqueur dans les leucémies myéloïdes. C R Acad Sci (Paris) 1992; 314 série III: 579-585.
9. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989; 8: 2975-81.
10. LeBaron RG, Zimmermann D, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem 1992; 267: 10003-10.
11. Bertrand P, Girard N, Delpech B, Duval C, d'Anjou J, Daucé JP. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas. Comparison between invasive and non invasive areas, Int J Cancer 1992; 52: 1-6.
12. Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier O, Tayot J, Creissard P. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumor stroma. Eur J Cancer 1993; 29A: 1012-17.
13. Delpech B, Vannier JP, Girard N, Bizet M, Delpech A, Lenormand B, Tilly H, Piguet H. Expression of the hyaluronan-binding glycoprotein hyaluronectin in leukemias. Leukemia 1993; 7: 172-6.
14. Ruoslahti E, Engvall E, Hyman E. Fibronectin: current concepts of its structure and function. Coll Res 1981; 1: 95-128.
15. Underhill CB, Toole BP. Binding of hyaluronate to the surface of cultured cells. J Cell Biol 1979; 82: 475-84.
16. Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res 1984; 161: 17-28.
17. Underhill CB, Tarone G, Kausz AT. The hyaluronate binding site from the plasma membrane is distinct from the binding protein present in brain. Conn Tissue Res 1987; 16: 225-35.
18. Klewes L, Turley E, Prehm P. The hyaluronate synthase from a eukaryotic cell line. Biochem J 1993; 290: 791-5.
19. Laurent T, Fraser JRE, Pertoft H, Smesrod B. Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem J 1986; 234: 653-8.
20. Turley E, Auersperg N. A hyaluronate binding protein transiently codistributes with p21k-ras in cultured cell lines. Exp Cell Res 1989; 182: 340-48.
21. Turley EA. Hyaluronic acid stimulates protein kinase activity in intact cells and in an isolated protein complex. J Biol Chem 1989; 264: 8951-5.
22. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
23. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 1990; 75: 589-95.
24. Murakami S, Miyake K, Abe R, Kincade PW, Hodes RJ. Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. J Immunol 1991; 146: 1422-7.
25. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990; 172: 69-75.
26. Morimoto K, Robin E, Le Bousse-Kerdiles MC, Li Y, Clay D, Jasmin C, Smadja-Joffe F. CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood 1994; 83: 657-62.
27. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptide with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343-8.
28. Thomas L, Byers HL, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 1992; 118: 971-7.
29. Hyman R, Lesley J, Schulte R. Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenet 1991; 33: 392-5.
30. Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP. The role and regulation of tumour-associated hyaluronan. In: The Biology of Hyaluronan: Ciba Foundation Symposium 143, Chichester: Wiley, 1989: pp. 150-69.
31. Delpech B, Bertrand P, Maingonnat C. Immunoenzymoassay of the hyaluronic acid - hyaluronectin interaction: application to the detection of hyaluronic acid in serum of normal subjects and cancer patients. Anal Biochem 1985; 149: 555-65.
32. Frebourg T, Lerebours G, Delpech B, Benhamou D, Bertrand P, Maingonnat C, Boulin C, Nouvet G. Serum hyaluronate in malignant pleural mesothelioma. Cancer 1987; 59: 2104-7.
33. Kumar S, West DC, Ponting JM, Gattamaneni HR. Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int J Cancer 1989; 44: 445-8.
34. Delpech B, Chevallier B, Reinhardt N, Julien JP, Duval C, Maingonnat C, Bastit P, Asselain B. Serum hyaluronan (hyaluronic acid) in breast cancer, Int J Cancer 1990; 46: 388-90.
35. Smadja-Joffe F, Moczar M, Le Bousse-Kerdiles C, Delpech B, Leibovich MP, Dufour F, Jasmin C. Increased synthesis of extracellular spleen glycosaminoglycans in an experimental myeloproliferative syndrome. Leukemia 1992; 6: 1011-19.
36. Darzenkiewicz Z, Balazs EA. Effect of connective tissue intercellular matrix on lymphocyte stimulation: I. Suppression of lymphocyte stimulation by hyaluronic acid. Exp Cell Res 1971; 66: 113-23.
37. Chevrier A, Girard N, Delpech B, Gilbert D. Inhibition of active E rosette forming T lymphocytes by hyaluronic acid. Evidence of a receptor for hyaluronic acid on a lymphocyte subpopulation. Biomed 1982; 36: 100-103.
38. Pessac B, Defendi V. Cell aggregation: role of acid mucopolysaccharides. Science 1972; 175: 898-900.
39. Wasteson A, Westermark B, Lindahl U, Pontén J. Aggregation of feline lymphoma cells by hyaluronic acid. Int J Cancer 1973; 12: 169-78.
40. Peluso GF, Perbellini A, Tajana GF. The effect of high and low molecular weight hyaluronic acid on mitogen-induced lymphocyte proliferation. Current Therapeutic Res 1990; 47: 437-43.
41. Chauzy C, Delpech B, Girard N, Olivier A. Formation de sphéroïdes mixtes par une coculture de cellules cancéreuses et de fibroblastes humains. C R Acad Sci (Paris) 1985; 301 série III: 387-392.
42. Goldberg RL, Toole BP. Hyaluronate inhibition of cell proliferation. Arthritis and Rheumatism 1987; 30: 769-78.
43. Lees VC, Fan TPD, West DC. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest 1995; 73: 259-66.
44. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 1996; 66: 664-8.
45. Toole BP. Glycosaminoglycans in morphogenesis. In: Hay ED. ed. Cell Biology of Extracellular Matrix. New York and London: Plenum Press. 1981: pp. 259-294.
46. Le Douarin N. Migration of neural crest cells. In: The Neural Crest. Cambridge: Cambridge University Press, 1982: pp. 28-45.
47. Morriss-Kay GM, Tuckett F, Solursh F. The effects of Streptomyces hyaluronidase on tissue organization and cell cycle time in rat embryos. J Embryol Exp Morphol 1986; 98: 59-70.
48. Perris R, Johansson S. Inhibition of neural crest cell migration by aggregating chondroitin sulfate proteoglycans is mediated by their hyaluronan-binding region. Develop Biol 1990; 137: 1-12.
49. Toole BP, Biswas C, Gros J. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci (USA) 1979; 76: 6299-303.
50. Thomas L, Etoh T, Stamenkovic I, Mihm MC, Byers HR. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 1993; 100: 115-20.
51. Turley EA, Austen L, Vandeligt K, Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of Ras-transformed cells. J Cell Biol 1991; 112: 1041-7.
52. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates In the uptake and degradation of hyaluronan. J Cell Biol 1992; 116: 1055-62.
53. Turley EA, Tretiak M. Glycosaminoglycan production by murine melanoma variants in vivo and in vitro. Cancer Rex 1985; 45: 5098-105.
54. Moczar M, Poupon MF, Moczar K. Hyaluronate-binding proteins in weakly and highly metastatic variants of rat rhabdomyosarcoma cells. Clin Exp Metastasis 1990; 8: 129-40.
55. Fraser JRE, Clarris BJ. On the reactions of human synovial cells exposed to homologous leucocytes in vitro. Clin Exp Immunol 1970; 6: 211-25.
56. Gately CL, Muul LM, Greenwood MA, Papazoglou S, Dick SJ, Kornblith PL, Smith B, Gately MK. In vitro studies on the cell-mediated immune response to human brain tumors: II. leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack. J Immunol 1984; 133: 3387-95.
57. Cameron E. Hyaluronidase and Cancer. Oxford: Pergamon Press. 1966.
58. Fiszer-Szafarz B, Szafarz D. Lysosomal hyaluronidase activity In normal rat liver and in chemically Induced hepatomas. Cancer Res 1973; 33: 1104-8.
59. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL. Association of elevated levels of hyaluronidase. a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 1996; 56: 651-7.
60. Liu D, Pearlman E, Diaconu K, Guo K, Mori H, Haqi T, Markowitz S, Willson J, Sy M-S. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci (USA) 1996; 91: 7832-7.